BRONZORAL Avant et pendant l'exposition au soleil
Food supplement declared in France, decision dated 13 March 2025
BRONZORAL Avant et pendant l'exposition au soleil (GAMARDE) is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: lutéine 5 mg per day, zéaxanthine 0.1 mg per day, Vaccinium myrtillus 430 mg per day, Bambusa bambos 48 mg per day, Vitis vinifera 3 mg per day. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.
- Brand
- GAMARDE
- Food business operator placing the product on the market
- LABORATOIRES DERMATOLOGIQUES GAMARDE
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 2 gélules par jour
- Directions for use
- 2 gélules par jour à prendre avec un grand verre d'eau
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Sun care
Declaration 145292, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Vaccinium myrtillus L. | Baie | Poudre (de plantes séchées ou broyées) | 430 mg |
| Bambusa bambos (L.) Voss | Exsudat | Autre extrait sec | 48 mg |
| Vitis vinifera L. | Pépin | Extrait sec hydroalcoolique | 3 mg |
Substances
| Name | Per day |
|---|---|
| lutéine | 5 mg |
| zéaxanthine | 0.1 mg |
Vitamins and minerals
Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).
| Declared form | Nutrient | EFSA limit, adults | Maximum dose in France |
|---|---|---|---|
| beta-carotene | β-Carotene | no limit (insufficient data) | no fixed dose |
| selenium enriched yeast | Selenium | 255 µg | 50 µg |
| L-ascorbic acid | Vitamin C | no limit (insufficient data) | 180 mg |
| D-alpha-tocopheryl acetate | Vitamin E | 300 mg | 30 mg |
| zinc sulphate | Zinc | 25 mg | 15 mg |
Additives
E470b
Other ingredients
Gélule végétale
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne pas dépasser la dose journalière recommandée. Tenir hors de portée des enfants. Les compléments alimentaires ne se substituent pas à une alimentation variée et équilibrée et à un mode de vie sain. Une protection solaire adaptée reste indispensable lors des expositions au soleil. Réservé aux adultes. Déconseillé aux femmes enceintes ou allaitantes.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Vaccinium myrtillus L.
Read the warning, when it applies and the studies cited
BILBERRY - VACCINIUM MYRTILLUS - Buccal
Route of administration: Buccal (Blumenthal et al. 2000)
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Health Canada monograph dated 30 January 2026
BILBERRY - VACCINIUM MYRTILLUS - Oral
Route of administration: Oral (Blumenthal et al. 2000)
Cautions and warnings
Condition of application: Relief of diarrhea.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.
Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.
Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Other declarations with the same name
In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.
- Bronzoral Avant et Pendant l'exposition au soleil Gamarde, declared in 2018 : different composition: 1 ingredient(s) added, 1 missing
Brand : GAMARDE
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “BRONZORAL Avant et pendant l'exposition au soleil (GAMARDE): composition and regulation”, https://compoatlas.com/en/supplements/products/145292-bronzoral-avant-et-pendant-l-exposition-au-soleil, updated 15 November 2026.